AMPH Q2 2017 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

AMPHAmphastar Pharmaceuticals, Inc.

$860M

Q2 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$65M-4.2% YoY

Gross Profit

$27M41.0% margin

Operating Income

$2M3.4% margin

Net Income

$2M3.0% margin

EPS (Diluted)

$0.04

QoQ Revenue Growth

+15.0%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

-$2M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$444M

Total Liabilities

$111M

Stockholders' Equity

$333M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$68M	-4.2%
Gross Profit	$27M	$32M	-15.7%
Operating Income	$2M	$10M	-78.8%
Net Income	$2M	$7M	-71.4%

Revenue Segments

Active Pharmaceutical Ingredient Segment

$1M100%

Geographic Segments

U

$64M100%